Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening

Area of Science:

• Biotechnology
• Computational Biology
• Pharmacology

Background:

• Peptide drug discovery is traditionally slow and resource-intensive.
• Machine learning (ML) offers computational solutions to expedite the identification and development of therapeutic peptides.
• ML leverages large datasets to predict peptide functionality with high accuracy.

Purpose of the Study:

• To review and compare state-of-the-art ML-based peptide prediction tools.
• To evaluate the performance of various ML algorithms in peptide therapeutics.
• To discuss challenges and future directions for ML in peptide research.

Main Methods:

• Comparative analysis of ML algorithms (SVM, Random Forest, Deep Learning).
• Assessment of feature encoding, prediction scores, and evaluation methodologies.
• Performance evaluation using independent datasets.

Main Results:

• ML approaches significantly enhance the speed and accuracy of therapeutic peptide prediction.
• Various ML tools demonstrate effectiveness in identifying functional peptides.
• The review provides insights into the strengths and limitations of different ML methods.

Conclusions:

• ML models are revolutionizing protein research and peptide-based drug discovery.
• Implementing ML can streamline the development pipeline for targeted peptide therapies.
• Addressing common pitfalls is crucial for maximizing the impact of ML in this field.